Navigation Links
Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London

LONDON, May 31, 2012 /PRNewswire/ --

When it comes to the evolving arena of pharmaceutical manufacturing, there are few events that can match the precedence of GDS International's Next Generation Pharmaceutical (NGP) Manufacturing Summit:

Always disruptive in its thought-leadership, this year's NGP Manufacturing summit will be hosted on the 17-19 September at the Radisson Edwardian Heathrow Hotel in London, UK - playing host to a 65-strong consortium of C-level executives and corporate officers from the region's most innovation and leading-edge pharmaceutical manufacturing firms. Positioned at the very pinnacle of industry movements, this year's summit promises to continue its trend as the most well respected event within the European Pharmaceutical industry.

Top C-level executives will be present to discuss cutting-edge business challenges, ranging from Operational Excellence and supply chain movements to regulatory impacts and traceability elements to name but a select few.

The Summit combines high-level roundtable discussions with next generation solutions that, together with the UK's Delegate Director, Francesca Swain, have been championed by the Summit's very own NG20 - populated with the industry's best-in-class thought-leaders - who have helped play a pivotal part in shaping the Summit's two-and-a-half day agenda and trends.

Included within the senior executive delegation are Olivier Rowland, EMEA Procurement Director at Merck Sharpe & Dhome; Merck's CISO, Frank Wagner; Regi Van Genechten, Senior Director of Supply Chain, Johnson & Johnson; Ingo Ebeling, Head of Technology & Product Support, Abbot Laboratories; and Novartis' Global Head of Purchasing IT, Philippe Gerwill.

Fabrizio Borin, Head of Production at Lundbeck Pharmaceuticals Italy, who attended the last NGP Manufacturing Summit at the Fairmont Le Montreux Palace, Switzerland, said: "It's a good, relaxed environment in which we have a chance to talk together, exchange ideas and create networks. A very good experience."

The event has been designed specifically for forward-thinking, C-level executives in the European Pharmaceutical manufacturing arena, drawing on experiences and discussing the challenges facing the sector. The NGP Manufacturing Summit will offer comprehensive, one-to-one meetings to give delegates the opportunity to meet with business analysts and solution providers to discuss strategy and technology demands in a rapidly evolving business climate.

Francesca Swain, GDS International's UK Delegate Director, believes the high calibre of speakers and exceptional content, combined with excellent networking opportunities, give the delegates and sponsors true value for money and a significant return on their investment.

"With just under four months until Europe's most significant Pharmaceutical Manufacturing Summit, we are delighted to announce the introduction of the NG20, which will ensure delegates receive a personal and relevant programme aimed at the highest level. We are pleased to be bringing together the top European pharmaceutical companies in one location at the same time.

"Key level executives will be in attendance, maximising every opportunity over the two-and-a-half days - and London will be a fantastic location to thrash out the current challenges facing the industry today. This is an exciting time for the European region, with the opportunity to shape the future of pharmaceutical manufacturing there for the taking."

For more information, please visit:

About GDS International

GDS International is one of the most innovative events and media companies worldwide - and a globally renowned producer of business-to-business summits, conferences, online information and advisory group gatherings. Founded in 1993, GDS International specialises in meeting the B2B marketing needs of our clients. Having a strong presence in mature industrial sectors but a finger on the pulse of emerging markets - as well as up-and-coming B2B business verticals - means we are perfectly placed to capitalise on the exciting developments brought about by the advent of a globalised economy. Our value proposition is simple: we deliver tangible business results from world-class events.

Contact: Rachel Sandeman

SOURCE GDS International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. COPD Tops Asthma as the Focus Indication for Next Generation Respiratory Therapies at the 2012 American Thoracic Society Conference
2. MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent
3. HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine
4. Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications
5. Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software at ISBER 2012 Annual Meeting
6. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
7. Life Technologies to Accelerate Adoption of Next-Generation Sequencing in HLA Through Key Partnerships
8. Genalyte, Inc. Completes $12 Million Series B Financing to Commercialize Its Maverick™ Next-Generation Multiplexing Platform
9. Awards for Drug Discovery Research for Frontotemporal Degeneration Announced
10. Isis Initiates Phase 1 Study in Patients With Cancer With the First Generation 2.5 Antisense Drug, ISIS-STAT3Rx
11. Stryker Launches Next Generation Heavy Duty Surgical Power Tools
Post Your Comments:
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
(Date:6/23/2016)... -- The Biotechnology industry might still be ... opportunities to investors. assesses the recent performances of ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ... complimentary trade alerts at: ...
(Date:6/23/2016)... , June 23, 2016 Leading BioSciences ... address medical conditions resulting from a breakdown of ... appointed Greg Doyle as chief executive ... BioSciences, executive management team and board of directors, ... financial officer. He will provide continued leadership and ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):